Nivolumab vs Observation in Resected Lung Cancer Study - Mirage News

Nivolumab vs Observation in Resected Lung Cancer Study Mirage News Post-Surgery Nivolumab Shows No DFS Improvement in EGFR/ALK-Negative NSCLC CancerNetwork